Abstract:IMPORTANCE Upper gastrointestinal tract cancer, including esophageal and gastric cancers, in China accounts for 50% of the global burden. Endoscopic screening may be associated with a decreased incidence of and mortality from upper gastrointestinal tract cancer. OBJECTIVE To evaluate the cost-effectiveness of endoscopic screening for esophageal and gastric cancers among people aged 40 to 69 years in areas of China where the risk of these cancers is high. DESIGN, SETTING, AND PARTICIPANTS For this economic evaluation, a Markov model was constructed for initial screening at different ages from a health care system perspective, and 5 endoscopic screening strategies with different frequencies (once per lifetime and every 10 years, 5 years, 3 years, and 2 years) were evaluated. The study was conducted between January 1, 2019, and October 31, 2020. Model parameters were estimated based on this project, government documents, and published literature. For each initial screening age (40-44, 45-49, 50-54, 55-59, 60-64, and 65-69 years), a closed cohort of 100 000 participants was assumed to enter the model and follow the alternative strategies. MAIN OUTCOMES AND MEASURES Cost-effectiveness was measured by calculating the incremental cost-effectiveness ratio (ICER), and the willingness-to-pay threshold was assumed to be 3 times the per capita gross domestic product in China (US $10 276). Univariate and probabilistic sensitivity analyses were conducted to assess the robustness of model findings. RESULTS The study included a hypothetical cohort of 100 000 individuals aged 40 to 69 years. All 5 screening strategies were associated with improved effectiveness by 1087 to 10 362 quality-adjusted life-years (QALYs) and increased costs by US $3 299 000 to $22 826 000 compared with no screening over a lifetime, leading to ICERs of US $1343 to $3035 per QALY. Screening at a higher frequency was associated with an increase in QALYs and costs; ICERs for higher frequency screening compared with the next-lower frequency screening were between US $1087 and $4511 per QALY. Screening every 2 years would be the most cost-effective strategy, with probabilities of 90% to 98% at 3 times the per capita gross domestic product of China. The model was the most sensitive to utility scores of esophageal cancer- or gastric cancer-related health states and compliance with screening. CONCLUSIONS AND RELEVANCE The findings suggest that combined endoscopic screening for esophageal and gastric cancers may be cost-effective in areas of China where the risk of these cancers is high; screening every 2 years would be the optimal strategy. These data may be useful for development of policies targeting the prevention and control of upper gastrointestinal tract cancer in China.

Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation

Preventable fractions of Gastric Cancer via national screening in Asian countries 2023–40: a population-based study (Preprint)

Cost-effectiveness Analysis of Multiple Gastric Cancer Screening Strategies in Northwest China Based on a Population Program: a Markov Modeling Study

Cost-Effectiveness Analysis of Helicobacter Pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model

The Long-Term Population Impact of Endoscopic Screening Programmes on Disease Burdens of Gastric Cancer in China: A Mathematical Modelling Study

Determining The Cost-Effectiveness Of Endoscopic Surveillance For Gastric Cancer In Patients With Precancerous Lesions

Personalizing age of gastric cancer screening based on comorbidity in China: Model estimates of benefits, affordability and cost-effectiveness optimization

Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050

Health Economic Evaluation on Population-Based Helicobacter Pylori Eradication and Endoscopic Screening for Gastric Cancer Prevention.

Cost-effectiveness of Helicobacter Pylori Screening to Prevent Gastric Cancer: Markov Decision Analysis

Screening for gastric cancer in China: Advances, challenges and visions

Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China

PCN198 THE BURDEN OF ESOPHAGEAL CANCER IN CHINA FROM 2013 TO 2030: A DYNAMIC COHORT MODELING STUDY

Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases.

Cost-effectiveness of population based Helicobacter pylori screening to prevent gastric cancer

Modeling the Cost-effectiveness of Esophageal Cancer Screening in China

PP64 Economic Evaluation for Esophageal Cancer Screening in China

Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study

Cost-Effectiveness of Lung Cancer Screening using Low-dose Computed Tomography in China: Policy Guidance Based on Start Age and Interval (Preprint)

Evaluation of long-term benefits and cost-effectiveness of nation-wide colorectal cancer screening strategies in China in 2020-2060: a modelling analysis

Both Family-Based Helicobacter Pylori Infection Control and Management Strategy and Screen-and-treat Strategy Are Cost-Effective for Gastric Cancer Prevention